KRISTI MONROE: Open Payments
NPI 1912581646 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 71 payments from 11 companies in 2025. Trend: 2023 $119 · 2024 $246 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $355 |
| Otsuka America Pharmaceutical, Inc. | 12 | $213 |
| Janssen Pharmaceuticals, Inc | 9 | $198 |
| Neurocrine BioSciences, Inc. | 8 | $178 |
| Alkermes, Inc. | 12 | $171 |
| ABBVIE INC. | 5 | $90 |
| Tris Pharma Inc | 1 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ARISTADA, REXULTI, VIVITROL.
Industry payments across VA — which companies pay providers there.
